Marek Śmiłowski

1.0k total citations
10 papers, 39 citations indexed

About

Marek Śmiłowski is a scholar working on Neurology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Marek Śmiłowski has authored 10 papers receiving a total of 39 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 3 papers in Infectious Diseases and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Marek Śmiłowski's work include Myasthenia Gravis and Thymoma (5 papers), Antifungal resistance and susceptibility (3 papers) and Multiple Sclerosis Research Studies (2 papers). Marek Śmiłowski is often cited by papers focused on Myasthenia Gravis and Thymoma (5 papers), Antifungal resistance and susceptibility (3 papers) and Multiple Sclerosis Research Studies (2 papers). Marek Śmiłowski collaborates with scholars based in Poland, Italy and Belgium. Marek Śmiłowski's co-authors include Przemysław Jałowiecki, Katarzyna Śmiłowska, D. S. Korobko, Renato Mantegazza, Kimiaki Utsugisawa, Małgorzata Krawczyk‐Kuliś, Li Liu, Lech Krawczyk, Jan De Bleecker and George Li and has published in prestigious journals such as Blood, Neurology and Neurotherapeutics.

In The Last Decade

Marek Śmiłowski

10 papers receiving 38 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Śmiłowski Poland 4 25 8 5 5 4 10 39
Abdullatif Al Khedr France 4 15 0.6× 23 2.9× 10 2.0× 5 1.0× 4 1.0× 7 41
Fatemeh Afrashteh Iran 4 10 0.4× 22 2.8× 3 0.6× 6 1.2× 7 1.8× 12 42
Agustina Lanöel Argentina 4 10 0.4× 10 1.3× 3 0.6× 2 0.4× 4 1.0× 10 33
Michala Jakubíková Czechia 3 60 2.4× 12 1.5× 3 0.6× 3 0.6× 25 6.3× 4 74
Astrid Eisenkölbl Austria 3 18 0.7× 4 0.5× 3 0.6× 1 0.2× 2 0.5× 8 27
Isabel Lentell United Kingdom 3 9 0.4× 11 1.4× 4 0.8× 5 1.3× 3 21
Michael Waltz United States 3 8 0.3× 31 3.9× 5 1.0× 7 1.4× 3 0.8× 6 51
Nieves Téllez Lara Spain 3 8 0.3× 24 3.0× 8 1.6× 4 0.8× 3 0.8× 3 32
Guillaume Vial France 5 4 0.2× 4 0.5× 6 1.2× 7 1.4× 16 50
Amanda Anderson United States 2 55 2.2× 5 0.6× 3 0.6× 5 1.0× 25 6.3× 2 82

Countries citing papers authored by Marek Śmiłowski

Since Specialization
Citations

This map shows the geographic impact of Marek Śmiłowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Śmiłowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Śmiłowski more than expected).

Fields of papers citing papers by Marek Śmiłowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Śmiłowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Śmiłowski. The network helps show where Marek Śmiłowski may publish in the future.

Co-authorship network of co-authors of Marek Śmiłowski

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Śmiłowski. A scholar is included among the top collaborators of Marek Śmiłowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Śmiłowski. Marek Śmiłowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Li, Guoping, Tuan Vu, D. S. Korobko, et al.. (2023). P276 Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC+. Neuromuscular Disorders. 33. S179–S179. 2 indexed citations
3.
4.
G, Li, Yuebing Li, Tuan Vu, et al.. (2023). Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis (P1-5.017). Neurology. 100(17_supplement_2). 1 indexed citations
5.
Farmakidis, Constantine, Maria Isabel Leite, Saskia Bresch, et al.. (2023). P273 Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis. Neuromuscular Disorders. 33. S178–S178. 1 indexed citations
6.
Śmiłowska, Katarzyna, et al.. (2022). Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor. Journal of Personalized Medicine. 12(3). 457–457. 3 indexed citations
7.
Saccardi, Riccardo, Manuela Badoglio, Joachim Burman, et al.. (2019). BEAM Vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society. Blood. 134(Supplement_1). 3313–3313. 2 indexed citations
8.
Śmiłowska, Katarzyna, et al.. (2015). Penetrating brain injury: a case report. PubMed. 47(3). 214–218. 5 indexed citations
9.
Szczechowski, L, Marek Śmiłowski, Grzegorz Helbig, Małgorzata Krawczyk‐Kuliś, & Sławomira Kyrcz‐Krzemień. (2015). Autologous hematopoietic stem cell transplantation (AHSCT) for aggressive multiple sclerosis – whom, when and how. International Journal of Neuroscience. 126(10). 867–871. 5 indexed citations
10.
Marszał, Elżbieta, et al.. (2003). Stan wiedzy na temat padaczki oraz postawy wobec osób dotkniętych tym schorzeniem. 12(23). 41–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdullatif Al Khedr Breakdown of academic impact, for papers by Fatemeh Afrashteh Breakdown of academic impact, for papers by Agustina Lanöel Breakdown of academic impact, for papers by Michala Jakubíková Breakdown of academic impact, for papers by Astrid Eisenkölbl Breakdown of academic impact, for papers by Isabel Lentell Breakdown of academic impact, for papers by Michael Waltz Breakdown of academic impact, for papers by Nieves Téllez Lara Breakdown of academic impact, for papers by Guillaume Vial Breakdown of academic impact, for papers by Amanda Anderson
Rankless by CCL
2026